Form 4: BioLife Solutions EVP Sells Shares for Tax Obligations

Aby J. Mathew, EVP & Chief Scientific Officer at BioLife Solutions Inc., sold 631 shares of common stock to satisfy tax withholding obligations.

Summary

• Aby J. Mathew, the Executive Vice President and Chief Scientific Officer of BioLife Solutions Inc. (BLFS), reported a transaction involving the company's common stock.
• The transaction, which occurred on December 9, 2025, was a sale of 631 shares of common stock.
• The shares were disposed of at a price of $25.13 per share, totaling approximately $15,869.03.
• Following this sale, Mathew's direct beneficial ownership of common stock stands at 349,755 shares.
• The sale was conducted under a Rule 10b5-1(c) trading plan, which was adopted by Mathew on March 8, 2024.
• The primary purpose of this sale was to cover tax withholding obligations associated with the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-planned sale of shares by an executive to cover tax withholding obligations, which is a neutral event and does not indicate a change in company fundamentals or executive confidence.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This insider transaction is a routine, pre-scheduled event for tax purposes and does not reflect broader industry trends or competitive positioning. It is specific to an individual executive's compensation and tax planning.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, pre-planned sale for tax purposes and not a discretionary sale indicating a change in executive sentiment or company outlook.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Keywords

BioLife Solutions, BLFS, Insider Trading, Form 4, Stock Sale, Executive Compensation, Tax Withholding, Rule 10b5-1